Marc Better is VP at Kite Pharma, Inc. (KITE). They have made 4 open-market trades across 1 company since 2015, most recently 2016-02-01.
CIK 0001510580
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KITE | 16,688 | $3.0M |
Shares reported on the most recent Form 4, priced at the 2016-02-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KITE | SELL | 2016-02-01 | 2016-02-03 | $47.31 | $419K | -0.8% | +20.4% | -0.4% |
| KITE | SELL | 2016-02-01 | 2016-02-03 | $47.34 | $426K | -0.8% | +20.4% | -0.4% |
| KITE | SELL | 2016-01-04 | 2016-01-05 | $61.52 | $547K | -8.9% | -22.7% | -17.6% |
| KITE | SELL | 2016-01-04 | 2016-01-05 | $61.53 | $554K | -8.9% | -22.7% | -17.6% |
| KITE | SELL · 10b5-1 | 2015-12-01 | 2015-12-03 | $76.31 | $687K | -16.7% | +2.4% | -11.0% |
| KITE | SELL · 10b5-1 | 2015-11-02 | 2015-11-04 | $71.07 | $640K | -16.7% | +2.4% | -25.6% |
| KITE | SELL · 10b5-1 | 2015-10-01 | 2015-10-02 | $54.81 | $493K | -16.7% | +2.4% | +2.4% |
| KITE | SELL · 10b5-1 | 2015-09-01 | 2015-09-03 | $51.81 | $466K | -16.7% | +2.4% | +2.4% |
| KITE | SELL · 10b5-1 | 2015-08-03 | 2015-08-04 | $72.14 | $649K | -16.7% | +2.4% | +2.4% |
| KITE | SELL · 10b5-1 | 2015-07-01 | 2015-07-02 | $61.90 | $557K | -16.7% | +2.4% | +2.4% |
| KITE | SELL · 10b5-1 | 2015-06-01 | 2015-06-03 | $54.60 | $491K | -16.7% | +2.4% | +2.4% |
| KITE | SELL · 10b5-1 | 2015-05-01 | 2015-05-05 | $50.72 | $456K | -16.7% | +2.4% | +2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.